1. Home
  2. LEDS vs HIND Comparison

LEDS vs HIND Comparison

Compare LEDS & HIND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SemiLEDS Corporation

LEDS

SemiLEDS Corporation

HOLD

Current Price

$2.07

Market Cap

12.2M

Sector

Technology

ML Signal

HOLD

HIND

Vyome Holdings Inc.

N/A

Current Price

$2.30

Market Cap

13.8M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
LEDS
HIND
Founded
2005
2017
Country
Taiwan
United States
Employees
N/A
18
Industry
Semiconductors
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
12.2M
13.8M
IPO Year
2010
2016

Fundamental Metrics

Financial Performance
Metric
LEDS
HIND
Price
$2.07
$2.30
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$15.00
AVG Volume (30 Days)
38.4K
17.6K
Earning Date
04-14-2026
05-20-2026
Dividend Yield
N/A
N/A
EPS Growth
53.12
N/A
EPS
N/A
N/A
Revenue
$43,009,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
729.81
N/A
52 Week Low
$1.01
$1.75
52 Week High
$3.37
$12.87

Technical Indicators

Market Signals
Indicator
LEDS
HIND
Relative Strength Index (RSI) 74.58 46.50
Support Level $2.02 $2.02
Resistance Level $2.17 $2.43
Average True Range (ATR) 0.18 0.13
MACD 0.06 0.01
Stochastic Oscillator 68.36 48.89

Price Performance

Historical Comparison
LEDS
HIND

About LEDS SemiLEDS Corporation

SemiLEDs Corp develops, manufactures, and sells light-emitting diode chips and LED components. The company's products include LED Chips, LED Components, and Lighting Products. Its products are used for general lighting applications, including street lights and commercial, industrial, system, and residential lighting; specialty industrial applications, such as ultraviolet, or Ultraviolet, curing of polymers, LED light therapy in medical/cosmetic applications, counterfeit detection, LED lighting for horticulture applications, architectural lighting and entertainment lighting. Substantial revenue is generated from the sale of LED components products. Geographically, it derives a majority of its revenue from Japan.

About HIND Vyome Holdings Inc.

Vyome Holdings Inc is a clinical-stage specialty pharmaceutical company working to treat immune-inflammatory and rare diseases of unmet need with next-generation therapeutic solutions. Its product candidates are: VT-1953, a topical gel that is being developed to treat signs and symptoms of malignant fungating wounds in cancer; VT-1908, a repurposed immune modulator to treat steroid-sparing anterior uveitis; and VB1953, which is being developed to treat moderate to severe acne. Vyome has also commercialized two novel reformulated topical anti-fungal products based on the technology platform of Molecular Replacement Therapeutics (MRT) in India: a dandruff lotion and shampoo. It operates in two segments: pharmaceutical products, which generate the maximum revenue, and biotechnology.

Share on Social Networks: